Analyst Ratings For Allergan PLC. (NYSE:AGN)
Today, Credit Suisse Group reiterated its Outperform rating on Allergan PLC. (NYSE:AGN) with a price target of $286.00.
There are 5 hold ratings, 12 buy ratings on the stock.
The current consensus rating on Allergan PLC. (NYSE:AGN) is Buy (Score: 2.71) with a consensus target price of $275.88 per share, a potential 11.96% upside.
Some recent analyst ratings include
- 7/20/2017-Credit Suisse Group Reiterated Rating of Outperform.
- 7/17/2017-Deutsche Bank AG Reiterated Rating of Buy.
- 7/14/2017-Piper Jaffray Companies Reiterated Rating of Hold.
- 6/16/2017-Cantor Fitzgerald initiated coverage with a Neutral rating.
Dividend information for Allergan PLC. (NYSE:AGN)
Allergan PLC. (NYSE:AGN) pays an annual dividend of Community Ranking: with a yield of 1.14% and an average dividend growth of 0.00% based on a 3 Year Average.
Dividend History for Allergan PLC. (NYSE:AGN)
- On 5/5/2017 Allergan PLC. announced a quarterly dividend of $0.70 0.01% with an ex dividend date of 5/16/2017 which will be payable on 6/15/2017.
- On 11/2/2016 Allergan PLC. announced a quarterly dividend of $0.70 with an ex dividend date of 2/24/2017 which will be payable on 3/28/2017.
- On 2/4/2015 Allergan PLC. announced a quarterly dividend of $0.05 0.09% with an ex dividend date of 2/5/2015 which will be payable on 3/20/2015.
- On 10/27/2014 Allergan PLC. announced a quarterly dividend of $0.05 with an ex dividend date of which will be payable on 12/11/2014.
- On 7/28/2014 Allergan PLC. announced a quarterly dividend of $0.05 0.12% with an ex dividend date of 8/13/2014 which will be payable on 9/5/2014.
- On 5/7/2014 Allergan PLC. announced a quarterly dividend of $0.05 0.12% with an ex dividend date of 5/21/2014 which will be payable on 6/13/2014.
- On 2/5/2014 Allergan PLC. announced a quarterly dividend of $0.05 0.17% with an ex dividend date of 2/26/2014 which will be payable on 3/21/2014.
Recent Insider Trading Activity For Allergan PLC. (NYSE:AGN)
Allergan PLC. (NYSE:AGN) has insider ownership of 0.36% and institutional ownership of 84.53%.
- On 5/18/2017 Nesli Basgoz, Director, sold 1,889 with an average share price of $220.45 per share and the total transaction amounting to $416,430.05. View SEC Filing
- On 3/2/2017 Paul Bisaro, Director, sold 70,000 with an average share price of $246.68 per share and the total transaction amounting to $17,267,600.00. View SEC Filing
- On 12/8/2016 Nesli Basgoz, Director, sold 500 with an average share price of $188.72 per share and the total transaction amounting to $94,360.00. View SEC Filing
- On 11/21/2016 Brent L. Saunders, CEO, bought 5,250 with an average share price of $189.13 per share and the total transaction amounting to $992,932.50. View SEC Filing
- On 11/11/2016 Maria Teresa Hilado, CFO, bought 1,422 with an average share price of $210.64 per share and the total transaction amounting to $299,530.08. View SEC Filing
- On 6/2/2016 Maria Teresa Hilado, CFO, bought 661 with an average share price of $241.57 per share and the total transaction amounting to $159,677.77. View SEC Filing
- On 5/11/2016 Nesli Basgoz, Director, sold 459 with an average share price of $225.10 per share and the total transaction amounting to $103,320.90. View SEC Filing
Recent Trading Activity for Allergan PLC. (NYSE:AGN)
Shares of Allergan PLC. closed the previous trading session at 246.41 up +0.56 0.23% with 1,149,737 shares trading hands.